Showing results (41-50 of 3,346) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|June 13, 2022
Considerations Around Coding the Membership Probability Function in a Latent Class Analysis: Renewed InsightsMarco Boeri, Brett Hauber, Joseph C Cappelleri
Pharmacoeconomics|December 14, 2020
The Application and Implications of Novel Deterministic Sensitivity Analysis MethodsRick A Vreman, Joost W Geenen, Saskia Knies, et al.
Pharmacoeconomics|January 11, 2021
What Did Time Tell Us? A Comparison and Retrospective Validation of Different Survival Extrapolation Methods for Immuno-Oncologic Therapy in Advanced or Metastatic Renal Cell CarcinomaSven L Klijn, Elisabeth Fenwick, Sonja Kroep, et al.
Pharmacoeconomics|June 19, 2017
Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health LossUlrikke J V Hernæs, Kjell A Johansson, Trygve Ottersen, et al.
Pharmacoeconomics|June 1, 2017
Simulation Modelling in Healthcare: An Umbrella Review of Systematic Literature ReviewsSyed Salleh, Praveen Thokala, Alan Brennan, et al.
Pharmacoeconomics|June 16, 2017
Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model UncertaintiesLaura Bojke, Bogdan Grigore, Dina Jankovic, et al.
Pharmacoeconomics|February 8, 2022
Economic Evaluation of Digital Health Interventions: Methodological Issues and Recommendations for PracticeManuel Gomes, Elizabeth Murray, James Raftery
Pharmacoeconomics|October 18, 2021
Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United KingdomSiu Hing Lo, Ksenija Gorni, C Simone Sutherland, et al.
Pharmacoeconomics|October 26, 2021
The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHSMegan Perry-Duxbury, James Lomas, Miqdad Asaria, et al.
Pharmacoeconomics|January 30, 2022
Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated VaccineZoë Pieters, Benson Ogunjimi, Philippe Beutels, et al.
Pageof 335